Investing RAD receives IND approval from US FDA for Betabart (RV-01) July 28, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post S&P 500 Breaking Out Again: What This Means for Your Portfolio July 28, 2025 Related Posts Western Copper and Gold Announces Upsized C$80 Million Bought Deal Financing February 13, 2026 RETRANSMISSION: Tartisan Nickel Corp. Intersects 11.0 Metres of 1.05% Ni, 0.33% Cu Including 2.0 Metres of 4.79% Ni, 1.25% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario February 13, 2026 Homeland Nickel Announces Homeland Share Distribution by Noble Mineral Exploration Inc. February 13, 2026
RETRANSMISSION: Tartisan Nickel Corp. Intersects 11.0 Metres of 1.05% Ni, 0.33% Cu Including 2.0 Metres of 4.79% Ni, 1.25% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario February 13, 2026
Homeland Nickel Announces Homeland Share Distribution by Noble Mineral Exploration Inc. February 13, 2026
